Answer
Cytotect CP Biotest (CMVIG) is used to prevent clinical manifestations of cytomegalovirus infection in patients receiving immunosuppressive therapy, particularly transplant recipients, with concomitant adequate virostatic agents to be considered.
Sources for this answer
- Cytotect CP BiotestGrifols UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated
Sources checked